FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32723611000001106: Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jun 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99871901000001116 Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99872001000001112 Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Is a Product containing precisely ascorbic acid 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has active ingredient Ascorbic acid false Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has specific active ingredient Ascorbic acid true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) 28 tablet Has AMP True Ascorbic acid 50mg tablets (Alissa Healthcare Research Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start